0.55
-0.0175(-3.11%)
Currency In USD
| Previous Close | 0.56 |
| Open | 0.55 |
| Day High | 0.56 |
| Day Low | 0.54 |
| 52-Week High | 350 |
| 52-Week Low | 0.51 |
| Volume | 586,102 |
| Average Volume | 5.69M |
| Market Cap | 5.6M |
| PE | -0.03 |
| EPS | -20.53 |
| Moving Average 50 Days | 0.92 |
| Moving Average 200 Days | 8.97 |
| Change | -0.02 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $0.55 as of April 29, 2025 at a share price of $0.545. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 1 year ago, it would be worth $0.52 as of April 29, 2025 at a share price of $0.545.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Conduit Pharmaceuticals Announces Leadership Changes
GlobeNewswire Inc.
Apr 16, 2025 12:30 PM GMT
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced key leadership changes to support the company’s next
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
GlobeNewswire Inc.
Apr 11, 2025 12:30 PM GMT
Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug approaches 2027 exclusivity expiration, pos
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
GlobeNewswire Inc.
Apr 10, 2025 12:30 PM GMT
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the “Company”) today announced that its Board of Directors has authorized a share repurchase program under which